Accueil>>Signaling Pathways>> Neuroscience>> Dopamine Receptor>>UCM-1306

UCM-1306 (Synonyms: 2-(Fluoromethoxy)-4'-(S-methylsulfonimidoyl)-1,1'-biphenyl)

Catalog No.GC70086

UCM-1306 est un modulateur allostérique positif (PAM) efficace par voie orale pour le récepteur D1 de la dopamine chez l'homme. UCM-1306 augmente l'effet maximal de la dopamine endogène dans les récepteurs D1 chez l'homme et la souris. En plus d'améliorer les symptômes moteurs, UCM-1306 peut également résoudre les troubles cognitifs clés associés à la maladie de Parkinson (PD) à long terme.

Products are for research use only. Not for human use. We do not sell to patients.

UCM-1306 Chemical Structure

Cas No.: 2258608-78-3

Taille Prix Stock Qté
10mg
216,00 $US
En stock
25mg
441,00 $US
En stock
50mg
702,00 $US
En stock
100mg
1 125,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for UCM-1306

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for UCM-1306

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.